Towards a precision immune checkpoint blockade immunotherapy in patients with colorectal cancer: Strategies and perspectives
Author:
Publisher
Elsevier BV
Subject
Pharmacology,General Medicine
Reference159 articles.
1. Epidemiology of colorectal cancer: incidence, mortality, survival, and risk factors;Rawla;Prz. Gastroenterol.,2019
2. Is There a Role for Programmed Death Ligand-1 Testing and Immunotherapy in Colorectal Cancer With Microsatellite Instability? Part II-The Challenge of Programmed Death Ligand-1 Testing and Its Role in Microsatellite Instability-High Colorectal Cancer;Marginean;Arch. Pathol. Lab Med,2018
3. The potential value of immunotherapy in colorectal cancers: review of the evidence for programmed death-1 inhibitor therapy;Toh;Clin. Colorectal Cancer,2016
4. PD-1/ PD-L1 blockade as a novel treatment for colorectal cancer;Yaghoubi;Biomed. Pharm.,2019
5. Mismatch repair deficient colorectal cancer in the era of personalized treatment;Hewish;Nat. Rev. Clin. Oncol.,2010
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Engineering metal-organic framework nanoparticles trigger pyroptosis to boost colon cancer immunotherapy;Materials & Design;2024-02
2. Neoadjuvant immunotherapy in colorectal cancer beyond immune checkpoint inhibitors: emerging from bench to bedside;Minerva Surgery;2023-07
3. Longitudinal change of circulating tumor cell level and its relationship with immune checkpoint inhibitor-based treatment benefits in unresectable, metastatic colorectal cancer patients;Scandinavian Journal of Clinical and Laboratory Investigation;2023-05-29
4. Somatic mutation profiling, tumor-infiltrating leukocytes, tertiary lymphoid structures and PD-L1 protein expression in HER2-amplified colorectal cancer;PeerJ;2023-05-02
5. Differential profile of protumor immunological factors between the tumor site and the tumor-free site – predictive potential of IL-8 and COX2 for colorectal cancer and metastasis;International Immunopharmacology;2023-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3